Science

Federal Bill Would Give Some Patients “Right to Try” Psychedelics

“The problem was that these wounds weren’t being addressed.”

Psychedelic Biotech in 2025: What’s Next? Featuring Florian Brand and Lars Wilde, Co-Founders of atai Life Sciences and Compass Pathways

Brought to you by our friends at Psychedelic Vantage

In Waves and War” Highlights Veterans’ Suffering, Psychedelic Hope

A new documentary on Netflix explores transformative potential of psychedelics for veterans, exploring groundbreaking treatments that offer hope, healing, and systemic change for those battling post-traumatic stress.

“From Forest to Dust” Shows How Drug Prohibition Drives Climate Crisis

PSA's Psychedelic State(s) of The Union: December 9, 2025

New Mexico to Accelerate Its Launch of Therapeutic Psilocybin Access, Plus: Advocacy Spotlight This Week: Interviewing the World's First "AI Psychedelic Patient" on 12/11, Writing the Psychedelic Future on 12/18, and more!

PSA's Sunday Sound-Off: December 7th, 2025

Does FDA Approval of Psychedelics = the End of Psychedelic Ballot Initiatives? Plus: Q4 Campaign Staffer Tell-All Part 5, PSA Advocacy Spotlight This Week: Interviewing the World's First "AI Psychedelic Patient", Writing the Psychedelic Future, and more!

Rise of the Psychedelic Aristocracy

From our friends at the Chronicles of Kykeon: Exploring the Emergence of a New Cultural Elite

PSA's Sunday Morning Sound-Off: November 30th, 2025

Say no to Psychedelic Hype Train PR Slop, Recapping PSA's debut Psychedelic Writers Guild Author Spotlight in NYC, Normalize Psychedelics Partnership Announcement, plus Vee Castillo takes PSA on a canna-tour of Thailand

PSA's Sunday Morning Sound-Off: November 23, 2025

Massachusetts hearing illuminates new state-level psychedelic lobbying activity, the psychedelic renaissance reaches Puerto Rico, and Attorney Kathryn Tucker brings psychedelics to the dying.